LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
circ-0016347 | miR-214 | caspase-1 | details | details
Moreover, circ-0016347 was identified as a sponge of miR-214 that upregulated the expression of caspase-1, which is the functional target of miR-214.
|
details
Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells.
|
Osteosarcoma | Oncotarget | 28424426 | |
DANCR | miR-214 | CTNNB1 | CTNNB1;CTNNB;MRD19;armadillo | details
Bacterial invasion of epithelial cells;Wnt signaling pathway;Hippo signaling pathway;Arrhythmogenic right ventricular cardiomyopathy (ARVC);Focal adhesion;Colorectal cancer;Adherens junction;Tight junction;Leukocyte transendothelial migration;Melanogenesis;Prostate cancer;Basal cell carcinoma;Pathogenic Escherichia coli infection;HTLV-I infection;Endometrial cancer;Proteoglycans in cancer;Pathways in cancer;Thyroid cancer
|
details
Association of DANCR with CTNNB1 blocked the repressing effect of microRNA (miR)-214, miR-320a, and miR-199a on CTNNB1.
|
details
Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1
|
Hepatocellular Carcinoma | Hepatology | 25964079 |
Plscr4 | miR-214 | Mfn2 | MFN2;CMT2A;CMT2A2;CPRP1;HSG;MARF | details | details
Collectively, these findings identify Plscr4 as a negative regulator of cardiac hypertrophy in vivo and in vitro due to its regulation of the miR-214-Mfn2 axis, suggesting that Plscr4 might act as a therapeutic target for the treatment of cardiac hypertrophy and heart failure.
|
details
The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214.
|
Cardiac Hypertrophy | Mol Ther Nucleic Acids | 29499950 |